Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Caspofungin in a pediatric patient with persistent candidemia.

Wertz KK, Pretzlaff RK.

Pediatr Crit Care Med. 2004 Mar;5(2):181-3.

PMID:
14987350
2.

Experience with caspofungin in the treatment of persistent fungemia in neonates.

Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M.

J Perinatol. 2005 Dec;25(12):770-7.

PMID:
16222348
3.

Comparison of caspofungin and amphotericin B for invasive candidiasis.

Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J; Caspofungin Invasive Candidiasis Study Group..

N Engl J Med. 2002 Dec 19;347(25):2020-9.

4.

Development of candidemia on caspofungin therapy: a case report.

Cheung C, Guo Y, Gialanella P, Feldmesser M.

Infection. 2006 Dec;34(6):345-8.

PMID:
17180591
5.

Caspofungin in combination with amphotericin B against Candida glabrata.

Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9.

6.
7.

Antifungal pharmacotherapy for neonatal candidiasis.

Bliss JM, Wellington M, Gigliotti F.

Semin Perinatol. 2003 Oct;27(5):365-74. Review.

PMID:
14626500
8.

Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.

Olver WJ, Scott F, Shankland GS.

Med Mycol. 2006 Nov;44(7):655-7.

PMID:
17071561
9.
10.

Antifungals in systemic neonatal candidiasis.

Frattarelli DA, Reed MD, Giacoia GP, Aranda JV.

Drugs. 2004;64(9):949-68. Review.

PMID:
15101785
11.

Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.

Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG.

Am J Ophthalmol. 2005 Jan;139(1):135-40.

PMID:
15652837
12.

Invasive candidiasis in cancer patients: observations from a randomized clinical trial.

DiNubile MJ, Hille D, Sable CA, Kartsonis NA.

J Infect. 2005 Jun;50(5):443-9.

PMID:
15907554
13.

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.

N Engl J Med. 2004 Sep 30;351(14):1391-402.

14.

Caspofungin for refractory candidemia in neonates.

Manzar S, Kamat M, Pyati S.

Pediatr Infect Dis J. 2006 Mar;25(3):282-3. No abstract available.

PMID:
16511405
15.

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.

Wingard JR, Wood CA, Sullivan E, Berger ML, Gerth WC, Mansley EC.

Clin Ther. 2005 Jun;27(6):960-9.

PMID:
16117996
16.

Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.

Natale F, Castronovo A, Regoli D, De Curtis M, Manzoni P.

Pediatr Infect Dis J. 2009 May;28(5):452. doi: 10.1097/INF.0b013e31819d1cf1. No abstract available.

PMID:
19295457
17.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.

Clin Infect Dis. 2007 Oct 1;45(7):883-93. Epub 2007 Aug 29. Erratum in: Clin Infect Dis. 2008 Jul 15;47(2):302.

PMID:
17806055
18.
19.
20.

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.

Gauthier GM, Nork TM, Prince R, Andes D.

Clin Infect Dis. 2005 Aug 1;41(3):e27-8. Epub 2005 Jun 28.

PMID:
16007519

Supplemental Content

Support Center